Andrographolide-Treated Bone Marrow Mesenchymal Stem Cells-Derived Conditioned Medium Protects Cardiomyocytes from Injury by Metabolic Remodeling

Investigators showed that Andrographolide-treated bone marrow MSCs (BMSCs)-conditioned medium (CM) could be more advantageous for cardiomyocyte injury repair than BMSCs-CM.